Influenza - Fred Hutchinson Cancer Research Center

Diseases / Research


Influenza prevalence rates in US

A simulated model depicting the prevalence of an influenza pandemic in the United States.

Chao et al. (2010) FluTE, a publicly available stochastic influenza epidemic simulation model. PLoS Comp Biol 6(1): e1000656.

Click for high-res version

Influenza research at Fred Hutch is conducted by the center’s Vaccine and Infectious Diseases Division (VIDD). Our work is focused on using statistical and modeling approaches to study influenza transmission and vaccine efficacy, as well as the design and analysis of vaccine studies.

Hutch researchers also collaborate with other health organizations to design and analyze vaccine studies.

Fast Facts

  • Influenza, also known as the flu, is a contagious illness caused by influenza viruses that are spread through respiratory droplets.
  • Adults experience mild to severe symptoms while seniors, children and patients with compromised immune systems are at risk for more serious and even life-threatening infection. Symptoms may include fever, cough, runny nose, muscle or body aches and fatigue.
  • Influenza viruses are primarily classified as Type A or B. Type B viruses are identified by their strain, while Type A viruses are divided into subtypes based on two proteins on the surface of the virus: hemagglutinin (H) and the neuraminidase (N).
  • Influenza can be prevented by receiving a vaccine that is administered as either a shot or nasal-spray. Vaccines are developed each season to protect against the three Influenza viruses that researchers predict will be the most common during the season. Influenza infections are treated using antivirals, the most common of which is oseltamivir, known as Tamiflu.

[back to top]

Prevention & Causes

Drug resistance - Center researchers used computer modeling to determine that the rapid spread of a Tamiflu-resistant strain of influenza A (H1N1) between 2006 and 2009 was likely due to a genetic mutation that increased transmissibility and not because of widespread over-prescription of Tamiflu. Learn more >

Pandemic planning - An outbreak of pandemic influenza in the United States could be mitigated with prompt implementation of social-distancing measures - such as school closures - combined with antiviral treatment and preventative medicine until a vaccine is available, according to findings by Center researchers. The analysis, led by Dr. Elizabeth (Betz) Halloran, was a coordinated effort by leading mathematical modeling centers. The research was part of a larger effort to guide national pandemic response planning. Learn more >

The design and analysis of vaccine studies - Researchers at the Center design and analyze data from vaccine trials. Dr. Halloran’s research group collaborates with the Program for Appropriate Technology in Health (PATH) on the design and analysis of the first trial of the effectiveness of influenza vaccine among children in rural Senegal, Africa. In addition to the analysis of actual trial data, Dr. Halloran remains a leading expert on the development of novel statistical approaches for estimating the efficacy and effectiveness of vaccines in field studies. Mathematical modeling efforts at the Center, led by Dr. Halloran, use these efficacy estimates to project the effectiveness of large-scale influenza vaccination campaigns. Under Dr. Halloran’s leadership, researchers have also estimated the efficacy of several non-pharmaceutical interventions against influenza (for example, the use of alcohol-based hand sanitizers in schools), most notably in collaboration with the Pittsburg Influenza Prevention Project.

Analysis of outbreak of novel influenza variants - In support of pandemic planning for influenza, Center researchers provide analytic support for field investigations of the outbreaks of novel influenza variants. Researchers, led by Dr. Halloran, have provided support to investigators at the Centers for Disease Control and Prevention (CDC), the Los Angeles County Department of Public Health, and Seattle & King County Public Health. Analyses conducted as part of these collaborations have led to an increased understanding of the dynamics of influenza transmission during the very early phases of the pandemic. Dr. Halloran’s research group is currently working with the CDC to analyze data related to the ongoing emergence of a novel swine variant of the influenza A H3N2 subtype. To be more proactive in preparing for future outbreaks of novel influenza variants, Dr. Halloran’s group recently obtained funding to support the development of novel statistical methods for the analysis outbreak investigation data, including real-time analytics support for prevention and control efforts.

[back to top]

Make an Appointment

Patients have access to cancer treatment developed by Fred Hutch at the Seattle Cancer Care Alliance, our clinical care partner.

Find a Trial

Clinical trials are vital to the development of innovative treatments for cancer and other related diseases.

Share Your Story

To help build community we are collecting first-person stories from those affected by cancer or related diseases.  Every story matters. Tell us your story so we can share it.

Volunteer for a Study

Volunteers play a key role in prevention and early detection research.


Support our quest for cures

Related Stories